Pharmacologic management of urinary incontinence

Clinics in Geriatric Medicine
David R Thomas

Abstract

Urinary incontinence is a highly prevalent and difficult to treat medical condition. For those who are affected, urinary incontinence produces profound modifications in lifestyle and perceived quality of life. Pharmacologic therapy clearly is beneficial for most types of urinary incontinence. The low therapeutic success of current treatments and obnoxious side effects, however, limit patient satisfaction and compliance. There is a considerable need for improved therapeutic options to treat this devastating condition.

References

Jan 14, 1998·Urology·W C de Groat
Jan 14, 1998·Urology·A F Brading
Jul 17, 2001·Journal of the American Geriatrics Society·J G Malone-LeeM F Maugourd
Jul 17, 2001·Journal of the American Geriatrics Society·J G OuslanderJ Schnelle
Dec 18, 2001·The Journal of Urology·Barry A O'ReillyStephen B McMahon
May 25, 2002·Journal of the American Geriatrics Society·Patricia S GoodeDavid L Roth
May 25, 2002·Journal of the American Geriatrics Society·Philip S WangJerry Avorn
Jun 13, 2002·International Journal of Urology : Official Journal of the Japanese Urological Association·Jeong Gu LeeTack Lee
Jul 20, 2002·The Journal of Urology·Roger R DmochowskiUNKNOWN Transdermal Oxybutynin Study Group
Jul 26, 2002·Pharmacoepidemiology and Drug Safety·K L L MovigA C G Egberts
Dec 24, 2002·Clinical Pharmacology and Therapeutics·Francesco LandiUNKNOWN Silvernet-HC Study Group
Jun 14, 2003·The Cochrane Database of Systematic Reviews·B MoehrerS Jackson
Jun 14, 2003·The Cochrane Database of Systematic Reviews·A AlhassoJ N'Dow
Jul 11, 2003·The Journal of Urology·UNKNOWN AUA Practice Guidelines Committee
Dec 19, 2003·The New England Journal of Medicine·John D McConnellUNKNOWN Medical Therapy of Prostatic Symptoms (MTOPS) Research Group

❮ Previous
Next ❯

Citations

Aug 25, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·H AllainM Djemai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved